Cellular Intelligence for Longevity and Regenerative Medicine.
XELGEN is the most advanced intelligence platform for unlocking precision longevity protocols.
By analyzing cellular change across 260,000+ biological markers, XELGEN helps clinicians understand how treatments perform, identify hidden risks, and optimize patient outcomes.
BUILT WITHIN JAPAN'S REGENERATIVE MEDICINE ECOSYSTEM.
Medicine measures organs. Longevity medicine must measure cells.
But aging, regeneration, and disease risk begin at the cellular level.
Longevity clinics providing advanced therapies need a way to:
XELGEN translates raw biological data into clinical decisions for longevity medicine.
Understanding your cellular change — so you know exactly what to do next.
Cell Intelligence refers to the ability to measure and interpret the biological signals that determine how cells function, adapt, and age.
Unlike traditional diagnostics that measure isolated biomarkers, XELGEN analyzes patterns of biological activity that reflect cellular health and resilience.
Biological Aging
Epigenetic clocks and methylation patterns that reveal true cellular age versus chronological age.
Cellular Stress
Markers of oxidative load, DNA damage response, and cellular senescence burden.
Metabolic Function
Mitochondrial efficiency, energy production capacity, and metabolic flexibility signals.
Regenerative Capacity
Stem cell activity signals, tissue repair potential, and immune regenerative markers.
Therapy Response
How cells adapt and respond to regenerative interventions over time — enabling outcome tracking.
The Clinical Outcome
This enables clinicians to move from reactive medicine to proactive longevity management.
XELGEN transforms biological signals into clinical insight.
The Cell Intelligence Framework maps the complete biological picture — from patient sample to clinical decision support.
Whole-system biological intelligence.
Most diagnostic tests evaluate biomarkers individually.
XELGEN analyzes marker interactions across biological systems.
Understanding these system-level interactions tells clinicians not only what is changing, but why.
7 core systems.
Up to 15 total.
Every XELGEN analysis includes all 7 core biological systems as standard. Specialist systems are added based on the patient's clinical focus — not every system is relevant to everyone, and that's exactly the point.
Detecting risk years earlier.
By mapping marker combinations, XELGEN surfaces risks that individual tests simply cannot detect. This allows clinicians to identify biological patterns that indicate emerging health risks — and act before they become clinical problems.
Early Risk Detection
Biological signals indicating emerging health risks — surfaced years before they appear in standard tests.
Future Health Prediction
AI models that project health trajectories based on cellular patterns, enabling proactive intervention.
Missed Risks Captured
Early health indicators often appear years before traditional diagnostics or standard methylation tests detect them.
more data than the Horvath biological age clock (353 markers).
585× more than 460-marker panels.
Standard biological age tests are like checking a single thermometer to understand a city's climate. They tell you one number — useful, but incomplete. XELGEN reads 260K+ individual data points — the equivalent of placing sensors across every neighbourhood, in every season, measuring every variable that determines how your cells are actually ageing, adapting, and responding to treatment. Blood tests tell you what's happening right now. Methylation tells you what has been happening for years — and what is likely to happen next.
Same framework. Completely different patient profiles.
Every XELGEN analysis uses the same 7 core biological systems — but the active signals differ entirely based on the patient's biology. Select a clinical profile to see how the Cell Intelligence framework maps each case.
Surgical recovery & repair is the dominant active system — with joint & cartilage health and immune inflammation co-activated, consistent with post-operative tissue remodelling and the angiogenesis cascade.
A customizable platform for your clinic.
XELGEN is designed specifically for clinics delivering advanced therapies such as:
Our platform provides white-label reports that clinics can brand and share with patients, allowing clinics to:
Measurable outcomes. Delivered to every patient.
Every XELGEN analysis generates a Cell Intelligence Report — a comprehensive clinical document that translates 260,000+ biological markers into actionable insights for clinicians and patients.
From sample to clinical insight.
Simple sample collection at home or in clinic using a test kit.
Blood data is processed using world-leading Illumina sequencing systems.
Our proprietary algorithm analyzes the full marker system as a biological network — not isolated markers.
Clinicians receive a Cell Intelligence Report — white-labeled and shareable with patients.
Reports can be white-labeled for clinics and shared directly with patients — reinforcing the clinic's brand and demonstrating measurable outcomes.
Designed for the future of longevity care.
XELGEN was developed in collaboration with clinics operating in Japan's regenerative medicine ecosystem.
This real-world clinical environment shaped the design of the Cell Intelligence Platform.
Partnered with clinics advancing regenerative medicine.
These clinics use XELGEN to better understand biological change and monitor therapy outcomes — delivering measurable evidence of cellular improvement to their patients.
A leading longevity clinic delivering advanced cellular therapies and precision regenerative protocols to patients across Japan.
A publicly listed Japanese biomanufacturer at the forefront of cell therapy production, supplying clinical-grade biological products to longevity programs across Asia.
Cell therapy biomanufacturer specialising in exosome-based biological products, with a focus on precision-formulated therapeutics for cellular rejuvenation and longevity clinics.
Science, insights & clinical intelligence.
Articles, technical notes, original research, and the latest news from the frontier of cellular longevity medicine.
The future of medicine
is cellular.
Longevity medicine requires new tools to measure biological health and guide interventions.
XELGEN provides the cellular intelligence layer that enables this transition.
See Cell Intelligence
in action.
Book a guided walkthrough of the XELGEN platform — from sample intake to the full Cell Intelligence report — tailored to your clinic's focus.
Prefer to reach out directly? [email protected]
Unlock Cellular
Intelligence.
See how XELGEN helps clinics measure cellular change and optimize longevity treatments.
Clinic inquiries: [email protected]